Issue link: https://beckershealthcare.uberflip.com/i/984530
47 DEVICES & IMPLANTS Top 10 orthopedic companies by market share — and where they'll be in 2022 By Laura Dyrda J ohnson & Johnson leads the ortho- pedic device market with a quarter of the market share; however, it's ex pected to drop around 3 percent over the next five years. Stryker, NuVasive and Globus Medical are expected to have slight gains over that time period while other leaders are also expected to drop. Here is the breakdown of 2016 market share and predictions for 2022, accord- ing to Statista. 1. Johnson & Johnson had 25.1 per- cent market share in 2016 and is expect- ed to have 22.8 percent in 2022. 2. Zimmer Biomet had 20.7 percent market share in 2016 and is expected to have 19.8 percent in 2022. 3. Stryker had 16.1 percent market share in 2016 and is expected to have 17.1 percent in 2022. 4. Medtronic had 7.9 percent market share in 2016 and is expected to have 8.4 percent in 2022. 5. Smith & Nephew had 5.7 percent market share in 2016 and is expected to have 5.5 percent in 2022. 6. Arthrex had 4.9 percent market share in 2016 and is expected to have the same, 4.9 percent, in 2022. 7. NuVasive had 2.5 percent market share in 2016 and is expected to have 2.9 percent in 2022. 8. Wright Medical Group had 2 percent market share in 2016 and is expected to have 2.9 percent in 2022. 9. Globus Medical had 1.6 percent market share in 2016 and is expected to have 2 percent in 2022. 10. Orthofix had 1.2 percent market share in 2016 and is expected to have 1.1 percent in 2022. n NuVasive introduces ALIF retractor for lateral, supine approaches: 5 insights By Megan Wood N uVasive unveiled its Anterior Lumbar Interbody Fusion Access. Here are five insights. 1. The ALIF Access is NuVasive's first Maximum Access Surgery ALIF retractor platform for both lateral and supine spine surgery. 2. For the lateral approach, the system can be integrated with the NuVasive XLIF procedure to perform single-position surgery for multilevel cases. 3. Using the ALIF Access system for the supine approach delivers enhanced imaging and direct visualization of the spine as well as access from the lateral decubitus position. 4. The system features a carbon fiber frame and a customizable retractor blade size. 5. The ALIF Access is compatible with the company's anterior implant portfolio. n 10 of the biggest orthopedic device company acquisitions in the past year By Laura Dyrda H ere are 10 of the biggest transactions in the orthopedic and spine device company space in 2017 and the early months of 2018. e transactions were large in terms of value and/or how they will shape industry development in the future. Integra LifeSciences acquired Johnson & Johnson's Codman Neurosurgery for around $1.05 billion in October. Stryker acquired Canadian imaging com- pany Novadaq Technologies for $701 mil- lion last year. Smith & Nephew acquired Rotation Med- ical, a tissue regeneration developer, for $210 million in December. Orthofix acquired Spinal Kinetics for around $105 million in March. Stryker acquired shares of Vexim for $97 million in October 2017. Wright Medical acquired Imascap, a so- ware-based solutions developer for preop- erative planning of shoulder replacement surgery, for about $88.8 million in cash and ordinary shares, in December 2017. Medtronic completed its $40 million invest- ment in Mazor Robotics to partner with the company on future innovation and assume exclusive global spine market commercial responsibility for the Mazor X Surgical As- surance Platform and accessories. Alphatec acquired SafeOp Surgical, a pri- vately held advanced neuromonitoring technology provider, for more than $18 million. RTI Surgical acquired Zyga Technology in January. e terms of the agreement were not disclosed, but Zyga brought in around $4 million in annual revenue prior to the acquisition. DePuy Synthes, a Johnson & Johnson sub- sidiary, acquired Innovative Surgical Solu- tions, a nerve localization technology com- pany known as Sentio, for an undisclosed amount. n